Sign in
4

Changes in Ownership

Scribe Therapeutics, Inc. Filed Acc 0000902664-26-003270

Director bought 2,391,238 shares at an average $15.16 ($36,259,761)

From the SEC's structured data for this filing

Trades in this filing

Aghazadeh Behzad · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-24 Purchase : show line 1 in the form +2,333,333 $15.00 $34,999,995 3,030,983 I
2026-07-24 Purchase : show line 2 in the form +50,000 $22.31 $1,115,500 3,080,983 I
2026-07-28 Purchase : show line 3 in the form +7,905 $18.25 $144,266 3,088,888 I
Open-market purchases · 2,391,238 sh · avg $15.16 · $36,259,761
Loading xslF345X06/ownership.xml…